NL192561C - Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten. - Google Patents

Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten. Download PDF

Info

Publication number
NL192561C
NL192561C NL8402463A NL8402463A NL192561C NL 192561 C NL192561 C NL 192561C NL 8402463 A NL8402463 A NL 8402463A NL 8402463 A NL8402463 A NL 8402463A NL 192561 C NL192561 C NL 192561C
Authority
NL
Netherlands
Prior art keywords
phenyl
compounds
compound
sodium
eye
Prior art date
Application number
NL8402463A
Other languages
English (en)
Dutch (nl)
Other versions
NL192561B (nl
NL8402463A (nl
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NL8402463A publication Critical patent/NL8402463A/nl
Publication of NL192561B publication Critical patent/NL192561B/xx
Application granted granted Critical
Publication of NL192561C publication Critical patent/NL192561C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8402463A 1983-08-10 1984-08-09 Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten. NL192561C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58146147A JPS6038323A (ja) 1983-08-10 1983-08-10 眼科用消炎剤
JP14614783 1983-08-10

Publications (3)

Publication Number Publication Date
NL8402463A NL8402463A (nl) 1985-03-01
NL192561B NL192561B (nl) 1997-06-02
NL192561C true NL192561C (nl) 1997-10-03

Family

ID=15401196

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402463A NL192561C (nl) 1983-08-10 1984-08-09 Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten.

Country Status (13)

Country Link
US (1) US4599360A (ja)
JP (1) JPS6038323A (ja)
BE (1) BE900345A (ja)
CA (1) CA1225033A (ja)
CH (1) CH660965A5 (ja)
DE (1) DE3429570C2 (ja)
DK (1) DK161668C (ja)
FR (1) FR2552993B1 (ja)
GB (1) GB2144993B (ja)
IT (1) IT1196220B (ja)
NL (1) NL192561C (ja)
SE (1) SE467909B (ja)
ZA (1) ZA846166B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179124A (en) * 1988-01-25 1993-01-12 University Of Iowa Research Foundation Anti-inflammatory for use in external and internal eye inflammations
US4968718A (en) * 1988-01-25 1990-11-06 University Of Iowa Research Foundation Topically effective, nonsteroidal drug for use in external and internal eye inflammations
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
ATE454157T1 (de) * 2000-11-08 2010-01-15 Fxs Ventures Llc L-histidin in ophthalmologischen lösungen
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
DK1339418T3 (da) * 2000-11-08 2009-12-14 Fxs Ventures Llc Forbedret ophthalmiske og kontaktlinseoplösninger indeholdende simple saccharider som konserverende forstærkere
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111825547B (zh) * 2019-04-23 2022-04-19 南京海融医药科技股份有限公司 一种芳基丙酸类化合物的盐及其制药用途
KR102200892B1 (ko) * 2019-05-13 2021-01-12 대원제약주식회사 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
KR102552315B1 (ko) * 2020-11-11 2023-07-06 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하며 위장장애 부작용이 저감된 약학적 조성물
KR102462607B1 (ko) * 2020-11-11 2022-11-03 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하는 안정성이 증가된 약학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3865949A (en) * 1973-08-02 1975-02-11 Upjohn Co Process of treatment
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPS5432460A (en) * 1977-08-16 1979-03-09 Sankyo Co Ltd Cycloalkylidenemethylphenylacetic acid derivative and their preparation
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
CH645539A5 (de) * 1980-06-09 1984-10-15 Sankyo Co Antiinflammatorische mittel fuer die aeusserliche anwendung.
JPS5757019A (en) * 1980-09-24 1982-04-06 Fujitsu Ltd Surface acoustic wave filter
JPS57106617A (en) * 1980-12-23 1982-07-02 Sankyo Co Ltd Analgesic and anti-inflammatory agent
JPS6033718B2 (ja) * 1981-06-27 1985-08-05 石川島播磨重工業株式会社 船舶の操舵装置
JPS58105939A (ja) * 1981-12-18 1983-06-24 Sankyo Co Ltd 置換フエニル酢酸誘導体及びその製法
JPS59196839A (ja) * 1983-04-21 1984-11-08 Sankyo Co Ltd フエニル酢酸誘導体

Also Published As

Publication number Publication date
SE8404019D0 (sv) 1984-08-08
BE900345A (fr) 1984-12-03
JPS6038323A (ja) 1985-02-27
IT1196220B (it) 1988-11-16
GB2144993B (en) 1987-03-11
NL192561B (nl) 1997-06-02
NL8402463A (nl) 1985-03-01
DK387784A (da) 1985-02-11
FR2552993B1 (fr) 1989-03-10
DK161668C (da) 1992-02-24
CH660965A5 (de) 1987-06-30
DK387784D0 (da) 1984-08-10
GB2144993A (en) 1985-03-20
FR2552993A1 (fr) 1985-04-12
DK161668B (da) 1991-08-05
SE467909B (sv) 1992-10-05
SE8404019L (sv) 1985-02-11
ZA846166B (en) 1985-04-24
IT8422291A0 (it) 1984-08-09
DE3429570C2 (de) 1995-02-02
CA1225033A (en) 1987-08-04
GB8420364D0 (en) 1984-09-12
DE3429570A1 (de) 1985-02-28
US4599360A (en) 1986-07-08

Similar Documents

Publication Publication Date Title
NL192561C (nl) Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten.
EP0326915B1 (en) A locally administrable therapeutic composition for inflammatory disease
Bauer et al. Treatment of experimental herpes simplex keratitis with acycloguanosine.
JPH08509205A (ja) β−シクロデキストリン誘導体及び治療剤を含んだ眼のための局所組成物
US5686450A (en) Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
GB2110532A (en) Bendazac compositions for treatment of cataract
WO1993010789A1 (en) The use of ob-104 to treat inflammation
FR2521856A1 (fr) Medicament ophtalmique pour le traitement des glaucomes, a base d'ethers-oxydes ou d'ether-oximes de derives alcoylamines
US5658950A (en) Therapeutic agent for glaucoma and ocular hypotensive agent
US5276044A (en) Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions
CA1333362C (en) Treatment of ocular inflammation
JPH026329B2 (ja)
US4797423A (en) Lysine salt of 4-diphenylacetic acid and its ophthalmic fomulations
US7745461B1 (en) Method of treating dry eye disorders
EP0885612A1 (en) Pirenoxine for the topical treatment of inflammatory conditions
AU778148B2 (en) 2-aminotetralin derivatives for the therapy of glaucoma
EP0375299A1 (en) Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma
US20020077358A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
EP1393277B1 (en) USE OF NF-Kappa-B INHIBITORS TO TREAT DRY EYE DISORDERS
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
EP0396169A2 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
WO2004069822A1 (ja) ステロイド副作用抑制組成物
AU2002309963A1 (en) Use of NF-KAPPA-B inhibitors to treat dry eye disorders
JP2002201129A (ja) 外眼部炎症疾患治療剤
JPH09295935A (ja) 抗眼炎症剤

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20020301